Lantern Pharma Inc (LTRN)
3.42 -0.07 (-2.01%) 04/17/25 [NASDAQ]
2.90 x 100 4.69 x 100
Realtime by (Cboe BZX)
2.90 x 100 4.69 x 100
Realtime - - (-) -
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | LTRN | DYAI | ATRA | ||
| Company | Lantern Pharma Inc | Dyadic International | Atara Biotherap | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.71 | 1.2200 | 5.84 | ||
| High | 3.71 | 1.2300 | 6.18 | ||
| Low | 3.27 | 1.2100 | 5.62 | ||
| Last | 3.42 | 1.2300 | 6.17 | ||
| Change | -0.07 | -0.0100 | +0.33 | ||
| % Change | -2.01% | -0.81% | +5.65% | ||
| Volume | 8,100 | 14,000 | 23,900 | ||
| 20-Day Average Volume | 42,840 | 31,055 | 47,350 | ||
| Previous Close | 3.49 | 1.2400 | 5.84 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.38 | 1.2974 | 6.10 | ||
| 20-Day Raw Stochastic | 59.59% | 23.65% | 59.90% | ||
| 20-Day Relative Strength | 47.17% | 41.53% | 45.41% | ||
| Weighted Alpha | -49.23 | -48.03 | -26.67 | ||
| Today's Opinion | 40% Sell | 56% Sell | 72% Sell | ||
| Previous Opinion | 40% Sell | 56% Sell | 88% Sell | ||
| Last Month's Opinion | 40% Sell | 8% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +12.50% since 04/10/25 | +2.50% since 04/10/25 | +16.42% since 04/10/25 | ||
| Low | 2.97 on 04/11/25 | 1.2000 on 04/16/25 | 5.16 on 04/11/25 | ||
| High | 3.92 on 04/15/25 | 1.2800 on 04/15/25 | 6.18 on 04/17/25 | ||
| 1-Month | |||||
| %Chg | -12.98% since 03/17/25 | -12.14% since 03/17/25 | -13.95% since 03/17/25 | ||
| Low | 2.55 on 04/08/25 | 1.1620 on 04/09/25 | 5.01 on 04/07/25 | ||
| High | 4.01 on 03/24/25 | 1.4806 on 03/18/25 | 7.21 on 03/19/25 | ||
| 3-Month | |||||
| %Chg | -7.32% since 01/17/25 | -18.00% since 01/17/25 | -6.09% since 01/17/25 | ||
| Low | 2.55 on 04/08/25 | 1.1620 on 04/09/25 | 5.01 on 04/07/25 | ||
| High | 6.12 on 01/24/25 | 1.7300 on 02/14/25 | 11.06 on 02/07/25 | ||
| 6-Month | |||||
| %Chg | +0.88% since 10/17/24 | +8.85% since 10/17/24 | -34.22% since 10/17/24 | ||
| Low | 2.55 on 04/08/25 | 1.0200 on 11/05/24 | 5.01 on 04/07/25 | ||
| High | 6.12 on 01/24/25 | 2.2000 on 12/18/24 | 18.70 on 01/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 36,885 | 37,012 | 36,149 | ||
| Shares Outstanding, K | 10,785 | 30,091 | 5,859 | ||
| Annual Sales | 0 | 3,500,000 | 128,940,000 | ||
| Annual Net Income | -20,780,000 | -5,810,000 | -85,400,000 | ||
| Last Quarter Sales | 0 | 820,000 | 32,750,000 | ||
| Last Quarter Net Income | -5,880,000 | -1,550,000 | -12,690,000 | ||
| 60-Month Beta | 1.63 | 0.98 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.54 on 03/27/25 | -0.05 on 03/26/25 | -1.19 on 03/07/25 | ||
| Latest Earnings Date | 05/08/25 | 05/13/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||